Hyperparathyroidism is a disorder in which one or more parathyroid glands release too much parathyroid hormone, or PTH. These four small glands sit behind the thyroid, but they control something very different: how your body balances calcium, phosphorus, and bone turnover. When PTH stays too high, the effects can spread quietly through the body for months or years. Some people notice fatigue, constipation, brain fog, kidney stones, or bone pain. Others feel well and only learn about it after routine blood work shows high calcium.
That mix of vague symptoms and important long-term risks is what makes hyperparathyroidism easy to miss. The good news is that it is usually diagnosable with a focused lab workup, and many cases, especially primary hyperparathyroidism, can be treated effectively. Understanding the type, the cause, and the right next step matters far more than guessing based on symptoms alone.
Key Insights
- Hyperparathyroidism can be silent for years while still increasing the risk of kidney stones, bone loss, and fractures.
- Primary hyperparathyroidism is often treatable with surgery, while secondary forms improve by addressing the underlying problem.
- Diagnosis usually requires calcium, PTH, kidney function, vitamin D, and sometimes urine testing and bone or kidney imaging.
- High-dose calcium or vitamin D should not be started on your own when calcium is abnormal.
- If calcium is repeatedly high, ask whether PTH, 25-hydroxyvitamin D, kidney function, and urine calcium have all been checked.
Table of Contents
- What Hyperparathyroidism Means
- Symptoms and Complications to Know
- Common Causes and Risk Factors
- How Diagnosis Is Confirmed
- Treatment Options and Surgery
- Monitoring and When to Seek Care
What Hyperparathyroidism Means
Hyperparathyroidism means the body is being exposed to too much parathyroid hormone. PTH helps regulate calcium in a tightly controlled way. When calcium falls, PTH rises to bring it back up by increasing calcium release from bone, changing how the kidneys handle calcium and phosphorus, and supporting activation of vitamin D so the gut absorbs more calcium. In a healthy system, that response is temporary and well balanced. In hyperparathyroidism, the signal stays switched on longer than it should.
The term is broad, and that is important because not all forms behave the same way.
Primary hyperparathyroidism starts in the gland itself. One or more parathyroid glands become overactive and secrete PTH even when the body does not need it. Blood calcium is often high, and this is the form most people mean when they talk about hyperparathyroidism in general.
Secondary hyperparathyroidism is a response to another problem outside the gland. The most common drivers are chronic kidney disease, vitamin D deficiency, low calcium absorption, or intestinal conditions that reduce nutrient uptake. In this setting, the gland is reacting to a real signal that calcium balance is off.
Tertiary hyperparathyroidism usually develops after long-standing secondary disease, especially in advanced kidney disease. Over time, the glands can become enlarged and continue releasing excess PTH even after the original trigger is partly corrected, which can push calcium high again.
Calcium helps nerves fire, muscles contract, the heart beat normally, and the skeleton stay strong. That is why PTH excess can affect so many systems at once. Hyperparathyroidism is not just “a calcium problem.” It can influence the kidneys, bones, mood, concentration, digestion, and energy level.
It also should not be confused with thyroid disease. The thyroid and parathyroid glands sit close together, but they regulate different hormones and cause different patterns of illness. Some people with hyperparathyroidism have very few symptoms, while others develop obvious complications. The type of hyperparathyroidism, the calcium level, kidney function, vitamin D status, and how long the condition has been present all shape what it feels like and how it is treated.
Symptoms and Complications to Know
One reason hyperparathyroidism is commonly overlooked is that the symptom pattern can be subtle. Many people are diagnosed after a routine metabolic panel shows elevated calcium before they ever connect their symptoms to a hormone disorder. Even so, the condition is not necessarily mild just because it feels mild.
Common symptoms often reflect hypercalcemia, or high calcium in the blood. These can include:
- Fatigue or unusual low stamina
- Muscle weakness
- Constipation
- Increased thirst
- Frequent urination
- Nausea or reduced appetite
- Trouble concentrating
- Irritability, low mood, or brain fog
Some people also notice more body aches than expected, especially in the muscles and joints. Others describe feeling “off” without a clear explanation. In older adults, the presentation can look like a general decline in energy, mood, memory, or balance rather than one dramatic symptom.
Over time, the bigger concerns are usually the kidneys and bones. Excess PTH increases bone turnover, which can reduce bone mineral density and raise fracture risk. It can also increase urinary calcium and contribute to stone formation. Anyone with repeated calcium elevations and flank pain, blood in the urine, or a history of kidney stones linked to high calcium should have hyperparathyroidism considered as part of the workup.
Complications can include:
- Osteopenia or osteoporosis
- Fragility fractures
- Kidney stones
- Nephrocalcinosis, or calcium deposition in the kidneys
- Reduced kidney function over time
Symptoms can differ somewhat by type. In secondary hyperparathyroidism from chronic kidney disease, symptoms may relate more to bone disease, mineral imbalance, itching, or the underlying kidney condition than to obvious hypercalcemia. In tertiary disease, features of both long-term kidney-related mineral imbalance and high calcium may appear.
Severe hypercalcemia is more urgent. Red flags include repeated vomiting, marked dehydration, worsening confusion, severe weakness, worsening abdominal pain, or heart rhythm symptoms such as palpitations. These are not symptoms to watch passively at home.
A key point is that symptom burden does not always match lab severity. Someone can feel only mildly unwell and still have bone loss or silent kidney stones. That is why persistent high calcium should not be dismissed as a harmless abnormality, especially when PTH is also elevated or “inappropriately normal.”
Common Causes and Risk Factors
The cause of hyperparathyroidism depends first on the type.
In primary hyperparathyroidism, the most common cause is a single benign parathyroid adenoma, which is a noncancerous growth in one gland. Some people instead have multigland hyperplasia, meaning several glands are enlarged and overactive. Parathyroid cancer is possible, but it is rare. Primary hyperparathyroidism is diagnosed more often in women and becomes more common with age, particularly after midlife.
Other factors that can raise suspicion for primary disease include:
- A family history of hyperparathyroidism or recurrent high calcium
- Inherited endocrine syndromes such as MEN1, and sometimes MEN2A
- Prior radiation exposure to the neck
- Long-term lithium use
- Certain medications, such as thiazide diuretics, which may reveal an already existing calcium problem rather than fully cause it
In secondary hyperparathyroidism, the glands are reacting to low calcium availability or impaired vitamin D handling. Chronic kidney disease is the classic example. When the kidneys cannot maintain normal phosphorus and vitamin D metabolism, PTH rises in compensation. Secondary hyperparathyroidism can also occur with malabsorption, celiac disease, inflammatory bowel disease, bariatric surgery, very low calcium intake, or untreated vitamin D deficiency. Because vitamin D strongly shapes calcium absorption, correcting low levels can be a major part of treatment in people who are also working on vitamin D levels and supplementation.
In tertiary hyperparathyroidism, the glands have been overstimulated for so long that they begin behaving autonomously. This is most often seen in advanced chronic kidney disease, dialysis, or after kidney transplantation in people whose parathyroid glands remain overactive.
A few additional conditions can complicate the picture. Familial hypocalciuric hypercalcemia, or FHH, is a genetic disorder that can mimic primary hyperparathyroidism on basic lab work. It usually causes lifelong mild hypercalcemia and low urine calcium, and it is treated very differently. That is one reason urine testing can matter so much.
The bigger clinical point is that high PTH is not a diagnosis by itself. It is a clue. To understand the cause, a clinician has to interpret PTH alongside calcium, phosphorus, kidney function, vitamin D status, medications, and sometimes family history. The right label changes the right treatment. A person with a parathyroid adenoma may need surgery, while someone with secondary hyperparathyroidism may improve most by treating kidney disease, replacing vitamin D, or correcting low calcium absorption.
How Diagnosis Is Confirmed
Hyperparathyroidism is diagnosed through pattern recognition, not one isolated lab result. A single mildly abnormal calcium level is not enough. Most clinicians first confirm that the calcium elevation is real and persistent, then ask whether the PTH level makes physiologic sense.
In primary hyperparathyroidism, the usual pattern is elevated calcium with an elevated PTH or a PTH that is technically within range but still too high for the calcium level. When calcium is high, PTH should normally be suppressed. If it is not, that is a major clue.
The core workup often includes:
- Repeat serum calcium, often corrected for albumin, or an ionized calcium level
- Intact PTH
- Kidney function testing, usually creatinine and estimated glomerular filtration rate
- Phosphorus
- 25-hydroxyvitamin D
- 24-hour urine calcium, when indicated
That urine test can help in two ways. It can estimate stone risk, and it can help distinguish primary hyperparathyroidism from familial hypocalciuric hypercalcemia, which tends to have low urine calcium. This distinction matters because surgery helps primary hyperparathyroidism but not FHH.
Once the biochemical diagnosis is clearer, doctors may assess organ effects. That often means:
- A DXA scan to measure bone density
- Vertebral imaging if fracture is suspected
- Kidney imaging such as ultrasound or CT if stones or nephrocalcinosis are possible
One common misconception is that a neck ultrasound or sestamibi scan is what diagnoses the condition. It does not. Imaging is mainly used after the decision for surgery has been made, to locate the overactive gland or glands. In other words, labs diagnose; imaging helps plan treatment.
Secondary hyperparathyroidism is diagnosed differently because the lab pattern is different. PTH is high, but calcium may be normal or low rather than high. Phosphorus and kidney function often help point toward chronic kidney disease, while low vitamin D or signs of malabsorption may point in another direction.
Because this workup can be nuanced, persistent calcium abnormalities, elevated PTH, recurrent kidney stones, or unexplained bone loss often justify a specialist review and, in many cases, a visit about when to see an endocrinologist. The diagnosis is usually very manageable once the pattern is recognized, but the wrong assumption early on can delay the right treatment.
Treatment Options and Surgery
Treatment depends on the type of hyperparathyroidism, the calcium level, symptom burden, and whether there is evidence of kidney or bone injury.
For primary hyperparathyroidism, parathyroidectomy is the only definitive cure. Surgery removes the overactive gland or glands. It is usually recommended for people who have symptoms, kidney stones, fractures, osteoporosis, reduced kidney function, clearly elevated calcium, or younger age at diagnosis. Many modern operations are focused and minimally invasive when preoperative localization is successful, but the best results still depend heavily on surgeon experience.
Parathyroid surgery can do more than normalize a lab value. It may reduce future stone risk, improve calcium balance, and protect the skeleton from ongoing hormone excess. Because long-term PTH excess can thin bone, treatment decisions are especially important in people already dealing with osteoporosis and hormone-related bone loss. Recovery is often straightforward, though temporary low calcium after surgery can occur and follow-up is essential.
Not everyone needs immediate surgery, and not everyone is a surgical candidate. When surgery is deferred, management may include:
- Good hydration
- Periodic calcium and kidney monitoring
- Bone density follow-up
- Maintaining a normal, not excessive, calcium intake
- Careful vitamin D replacement if levels are low
Medication can also help in selected cases. Cinacalcet can lower serum calcium and PTH, but it does not reliably rebuild bone density. Bisphosphonates or denosumab can improve bone density, though they do not correct the underlying overactive gland. These medicines are supportive, not curative, in primary disease.
For secondary hyperparathyroidism, treatment focuses on the cause. That may include:
- Correcting vitamin D deficiency
- Improving calcium intake or absorption when appropriate
- Managing chronic kidney disease and phosphorus balance
- Using active vitamin D analogs or calcimimetics in kidney-related cases
For tertiary hyperparathyroidism, the glands may stay autonomous even after the original trigger improves, and surgery is often considered when medical therapy is no longer enough.
Pregnancy requires a more specialized plan. Mild cases may be monitored closely, but significant hypercalcemia can be dangerous for both parent and baby, so obstetric and endocrine input becomes important early.
The bottom line is simple: primary hyperparathyroidism is often surgically curable, while secondary and tertiary forms usually require a broader metabolic or kidney-focused treatment strategy.
Monitoring and When to Seek Care
Even when hyperparathyroidism does not require immediate surgery, it should not be ignored. Follow-up helps answer two practical questions: Is the calcium level staying stable, and is the condition harming the kidneys or bones over time?
Monitoring plans vary, but many people need regular review of:
- Serum calcium
- Kidney function
- Vitamin D status
- Bone density over time
- Urine calcium or kidney imaging when clinically indicated
If primary hyperparathyroidism is being observed rather than operated on, changes that often push treatment toward surgery include a higher calcium trend, a new kidney stone, a fragility fracture, worsening bone density, or falling kidney function.
Daily habits matter too. Hydration is especially important, because dehydration can worsen hypercalcemia. People with elevated calcium are often advised to drink enough fluids consistently, particularly during hot weather, illness, or heavy exercise. It is also wise to review all medications and supplements with a clinician. Calcium tablets, vitamin D, lithium, and some blood pressure medicines can complicate the picture. That does not mean they should be stopped abruptly, only that they should be part of the discussion.
A few practical habits can reduce trouble between visits:
- Keep copies of lab trends, not just one result
- Report new stone symptoms, fractures, or worsening constipation
- Mention mood changes, brain fog, or unusual weakness
- Avoid starting high-dose supplements without guidance
- Ask whether abnormal calcium has been rechecked with PTH
Urgent care is warranted if high calcium is causing confusion, repeated vomiting, severe dehydration, pronounced weakness, chest symptoms, or severe abdominal pain. Those symptoms can signal more dangerous hypercalcemia and should not wait for a routine follow-up.
Specialist care is especially important when the diagnosis is unclear, calcium remains high, PTH stays elevated, kidney disease is present, pregnancy is involved, or there is concern for an inherited syndrome. For many people, the right next step is a focused review of labs and imaging rather than more guessing. A clear specialist plan can prevent years of vague symptoms, unnecessary worry, and missed organ damage.
With timely diagnosis and appropriate treatment, the outlook is often very good. The key is not to normalize persistent calcium abnormalities just because the symptoms seem nonspecific.
References
- Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop 2022 (Guideline). ([PubMed][1])
- European Expert Consensus on Practical Management of Specific Aspects of Parathyroid Disorders in Adults and in Pregnancy: Recommendations of the ESE Educational Program of Parathyroid Disorders 2022 (Guideline). ([PubMed][2])
- Primary Hyperparathyroidism: A Narrative Review of Diagnosis and Medical Management 2021 (Review). ([PubMed][3])
- Primary hyperparathyroidism: clinical manifestations, diagnosis and evaluation according to the Fifth International Workshop guidelines 2023 (Review). ([PubMed][4])
- Hyperparathyroidism (primary): diagnosis, assessment and initial management 2019 (Guideline). ([NICE][5])
Disclaimer
This article is for general educational purposes and is not a substitute for personal medical advice, diagnosis, or treatment. Hyperparathyroidism can overlap with other causes of high calcium, kidney stones, fatigue, and bone loss, so lab interpretation should be done by a qualified clinician. Seek urgent medical care for confusion, repeated vomiting, severe weakness, dehydration, chest symptoms, or other signs of significant hypercalcemia. Do not start or increase calcium or vitamin D supplements without medical guidance if your calcium level is already abnormal.
If you found this article useful, please consider sharing it on Facebook, X, or another platform you use professionally or personally.
